Schmaier A H, Gustafson E, Idell S, Colman R W
J Lab Clin Med. 1984 Dec;104(6):882-92.
The assay of plasma prekallikrein requires activation of prekallikrein to kallikrein and sufficient inactivation of the plasma protease inhibitors of kallikrein to accurately measure the generated kallikrein activity. One method of elimination of the plasma protease inhibitors to kallikrein is to chemically pretreat the plasma. Methylamine has previously been employed to selectively inactivate alpha 2-macroglobulin. Our study examines the effect of sequential preincubation of plasma with chloroform and methylamine on the plasma prekallikrein assay. Chloroform was demonstrated to be a chemical inhibitor of purified C-1 inhibitor, but alpha 2-macroglobulin was not. Chloroform inhibition of C-1 inhibitor was not caused by precipitation of the protein into the interface between the water and organic solvent phase. Greater than 95% of C-1 inhibitor antigen was recovered in the supernatant of chloroform-treated purified C-1 inhibitor, and chloroform-saturated buffer inhibited purified C-1 inhibitor. Chloroform did not dissociate a preformed complex of kallikrein and C-1 inhibitor, but its inhibition of C-1 inhibitor was reversible. The addition of methylamine to plasma pretreated with chloroform in the plasma prekallikrein assay allowed for only a slight increase in the amount of kallikrein measured at 1 minute kaolin activation times, but provided for sustained measurement of activated prekallikrein when kaolin activation times were 5 to 7 minutes. Without chemical pretreatment, prekallikrein was not measurable in rabbit plasma. Both rabbit and pig plasma prekallikrein was measurable after exposure of the plasma to chloroform and methylamine, although the peak activation times and the contribution of each animals' protease inhibitors varied with the species. Our results show that chloroform is a reversible inhibitor of C-1 inhibitor, and that the plasma prekallikrein assay in which it is used is useful for the measurement of prekallikrein in nonhuman mammalian plasma samples.
血浆前激肽释放酶的测定需要将前激肽释放酶激活为激肽释放酶,并充分灭活激肽释放酶的血浆蛋白酶抑制剂,以准确测量所产生的激肽释放酶活性。消除血浆中激肽释放酶的蛋白酶抑制剂的一种方法是对血浆进行化学预处理。此前已使用甲胺选择性灭活α2-巨球蛋白。我们的研究考察了血浆先后用氯仿和甲胺预孵育对血浆前激肽释放酶测定的影响。已证明氯仿是纯化的C-1抑制剂的化学抑制剂,但对α2-巨球蛋白不是。氯仿对C-1抑制剂的抑制作用不是由蛋白质沉淀到水相和有机相之间的界面引起的。在氯仿处理的纯化C-1抑制剂的上清液中回收了超过95%的C-1抑制剂抗原,并且氯仿饱和缓冲液抑制纯化的C-1抑制剂。氯仿不会解离预先形成的激肽释放酶和C-1抑制剂复合物,但其对C-1抑制剂的抑制作用是可逆的。在血浆前激肽释放酶测定中,向用氯仿预处理的血浆中添加甲胺,在高岭土激活时间为1分钟时,测得的激肽释放酶量仅略有增加,但当高岭土激活时间为5至7分钟时,可实现对活化前激肽释放酶的持续测量。未经化学预处理时,兔血浆中无法检测到前激肽释放酶。血浆经氯仿和甲胺处理后,兔和猪血浆中的前激肽释放酶均可检测到,尽管每种动物的蛋白酶抑制剂的峰值激活时间和贡献因物种而异。我们的结果表明,氯仿是C-1抑制剂的可逆抑制剂,并且使用氯仿的血浆前激肽释放酶测定法可用于测量非人类哺乳动物血浆样本中的前激肽释放酶。